Evidence map›Paper›PMID 32042772›Full record

ArticleAnnals of translational medicine2019

Catalpol induces cell activity to promote axonal regeneration via the PI3K/AKT/mTOR pathway

Jinghuan Wang, Dong Wan, Guoran Wan, Jianghong Wang, Junhui Zhang, Huifeng Zhu

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Iridoids rich fraction fromFrontiers in molecular neuroscience · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Luminescent Human iPSC-Derived Neurospheroids Enable Modeling of Neurotoxicity After Oxygen-glucose Deprivation.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Article
  15. Comprehensive Analysis of the Effect of 20(Molecules (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Terpenoid natural products exert neuroprotectionFrontiers in pharmacology · 2022
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jinghuan WangCollege of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing 400715, China.
Dong WanDepartment of Emergency & Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Guoran WanDepartment of Clinic Medicine, Chongqing Medical University, Chongqing 400016, China.
Jianghong WangDepartment of Emergency & Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Junhui ZhangHealth Management Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Huifeng ZhuCollege of Pharmaceutical Sciences and Traditional Chinese Medicine, Southwest University, Chongqing 400715, China.
Chongqing Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CNSouthwest University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate the role and mechanism of catalpol on neuronal cell activity to promote axonal regeneration via PI3K/AKT/mTOR pathway after stroke.

methods

resultsRepeated treatments with catalpol improved neurological score and significantly enhanced neuronal cell activity, then promote axonal regeneration after stroke. While

conclusionsThese results suggested that catalpol might contribute to internal neuronal cell activity and axonal regeneration by regulating PI3K/AKT/mTOR pathway.

Indexed as

Axonal regenerationCatalpolcell activityPI3K/AKT/mTORstroke in vitro & in vivo

Identifiers

PMID32042772
PMCPMC6989990
OpenAlexW2995467267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.